INCY Incyte

Q2 2025 10-Q

Filed: Jul 29, 2025Period ending Jun 30, 2025

Industrials

Services-Commercial Physical & Biological ResearchSEC EDGAR

Incyte (INCY) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 29, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Management Discussion & Analysis

• Revenue $1,215.5M Q2 2025, up 16.4% YoY from $1,043.8M Q2 2024; 6-month revenue $2,268.4M up 17.9% YoY
• Net income $405.0M Q2 2025 vs loss $444.6M Q2 2024; operating expenses R&D $494.9M Q2 2025 vs $1,138.4M Q2 2024

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.2B

Net Income

$405M

Operating Margin

43.6%

Net Margin

33.3%

Source: XBRL data from Incyte Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Incyte Quarterly Reports

Q3 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Incyte

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.